Й‡ќй‡‘иґ­д№°жћёз‰№зѕ‘зєўе«©е¦№зѕће°џдёѓиє«жќђи‹—жќўзѕћи…їзѕћи‡ђе¤§иѓ†жњ‘ж€˜ж€·е¤–йњіе‡єеџљдёћйљ”ејѓиђѓзћ‹з§џе®ўйђ З€±еґ—е›ѕ331p И§†... < Editor's Choice >

Research indicates that miR-331-3p promotes chemoresistance in pancreatic cancer by activating the Wnt/β-catenin pathway and suppressing the ST7L gene. Often upregulated in patient plasma, this microRNA serves as a potential biomarker for monitoring treatment efficacy. Access the full study via SAGE Journals .

Research indicates that miR-331-3p promotes chemoresistance in pancreatic cancer by activating the Wnt/β-catenin pathway and suppressing the ST7L gene. Often upregulated in patient plasma, this microRNA serves as a potential biomarker for monitoring treatment efficacy. Access the full study via SAGE Journals .